Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1635-1641

  Khalil, Hayssam ^a   Chen, Tao ^a,b   Riffon, Renée ^a   Wang, Rutao ^a   Wang, Zhao ^a  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^b Shaanxi Liposome Research Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CARBENICILLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; NORFLOXACIN; NOVOBIOCIN; OFLOXACIN; PIPERACILLIN; POLYETHYLENEIMINE; POLYMYXIN B; RIFAMPICIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; NOVOBIOCIN; OFLOXACIN; PIPERACILLIN; POLYETHYLENEIMINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RIFAMPIN; TICARCILLIN; TOBRAMYCIN;

EID: 42949168882     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01071-07     Document Type: Article

References (30)

1. Ayres, H. M., J. R. Furr, and A. D. Russell. 1998. Effect of divalent cations on permeabilizer-induced lysozyme lysis of Pseudomonas aeruginosa. Lett. Appl. Microbiol. 27:372-374.
2. Bell, A., M. Brains, and R. E. W. Hancock. 1990. Pseudomonas aeruginosa outer membrane OprH: expression from the cloned gene and function in EDTA and gentamicin resistance. J. Bacteriol. 173:6657-6664.
3. Bereenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130.
4. Champlin, F. R., M. L. Ellison, J. W. Bullard, and R. S. Conrad. 2005. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 26:159-164.
5. Clinical and Laboratory Standards Institute. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Clinical and Laboratory Standards Institute, Villanova, PA.
6. Davis, P. B., M. Drumm, and M. W. Konstan. 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
7. Gotoh, N. 2001. Antibiotic resistance caused by membrane impermeability and multidrug efflux systems. Nippon Rinsho 59:712-718.
8. Helander, I. M., H. Alakomi, K. Latva-Kala, and P. Koski. 1997. Polyethylenimine is an effective permeabilizer of gram-negative bacteria. Microbiology 143:3193-3199.
9. Helander, I. M., K. Latva-Kala, and K. Lounatmaa. 1998. Permeabilizing action of polyethylenimine on Salmonella typhimurium involves disruption of the outer membrane and interactions with lipopolysaccharide. Microbiology 144:385-390.
10. Karlowsky J. A., G. A. Harding, S. A. Zelenitsky, D. J. Hoban, A. Kabani, T. V. Balko, M. Turik, and G. G. Zhanel. 1997. In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species. Antimicrob. Agents Chemother. 41:2576-2578.
11. Kwon, D. H., and C. D. Lu. 2006. Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1623-1627.
12. Labischinski, H., G. Barnickel, H. Bradaczek, D. Naumann, E. T. Rietschel, and P. Giesbrecht. 1985. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J. Bacteriol. 162:9-20.
13. Lambert, R. J., G. W. Hanlon, and S. P. Denyer. 2004. The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa. J. Appl. Microbiol. 96:244-253.
14. Leonard, A., T. Leal, and P. Lebecque. 2007. Cystic fibrosis and Pseudomonas aeruginosa: current and future strategies. J. Pharm. Belg. 62:25-28.
15. Marelich, G. P., and C. E. Cross. 1996. Cystic fibrosis in adults. From researcher to practitioner. West. J. Med. 164:321-334.
16. Modha, J. L., K. J. Barrett-Bee, and R. J. Rowbury. 1990. Enhancement by cationic compounds of the growth inhibitory effect of novobiocin on Escherichia coli. Lett. Appl. Microbiol. 8:219-222.
17. Nikas, T. I., and R. E. W. Hancock. 1983. Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. J. Bacteriol. 153:281-285.
18. Ostronoff, M., F. Ostronoff, A. Sucupira, A. P. Souto Maior, M. Caniza, and R. Florencio. 2006. Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampin. Int. J. Infect. Dis. 10:339-340.
19. Pier, G. B. 1986. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J. Infect. Dis. 151:575-580.
20. Ramsey, B. W. 1996. Management of pulmonary disease in patients with cystic fibrosis. N. Engl. J. Med. 335:179-188.
21. Russell, A. D. 1982. Modificatrion of the bacterial cell envelope and enhancement of antibiotic susceptibility, p. 119-168. In C. H. Stuart-Harris and D. M. Harris (ed.), The control of antibiotic-resistant bacteria. Academic Press, Inc., New York, NY.
22. Sakata, K., H. Yajima, K. Tanaka, Y. Sakamoto, K. Yamamoto, A. Yoshida, and Y. Dohi. 1993. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am. Rev. Respir. Dis. 148:1061-1065.
23. Tarn, V. H., A. N. Schilling, G. Vo, S. Kabbara, A. L. Kwa, and N. P. Wiederhold. 2005. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3624-3630.
24. Vaara, M. 1990. The effect of oligolysines Lys-3, Lys-4 and Lys-5 on the outer membrane permeability of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 55:15-19.
25. Vaara, M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
26. Vaara, M., and J. Jaakkola. 1989. Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. Antimicrob. Agents Chemother. 33:1741-1747.
27. Vasil, M. L. 1986. Pseudomonas aeruginosa mechanism of virulence epidemiology. J. Pediatr. 108:800-805.
28. Waters, V., and F. Ratjen. 2006. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues. Expert Rev. Anti-Infect. Ther. 4:807-819.
29. White, R. L., D. S. Burgess, M. Manduru, and J. A. Bosso. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checker-board, and E test. Antimicrob. Agents Chemother. 40:1914-1918.
30. Yokoyama, T., M. Sugai, M. Ohara, and Y. Imamura. 2007. Multi-drug resistant Pseudomonas aeruginosa infection. J. Nippon Rinsho 65(Suppl. 3):418-422.